Essex Investment Management CO LLC Ligand Pharmaceuticals Inc Transaction History
Essex Investment Management CO LLC
- $443 Million
- Q1 2025
A detailed history of Essex Investment Management CO LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Essex Investment Management CO LLC holds 61,702 shares of LGND stock, worth $6.5 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
61,702
Previous 65,247
5.43%
Holding current value
$6.5 Million
Previous $6.99 Million
7.21%
% of portfolio
1.47%
Previous 1.35%
Shares
4 transactions
Others Institutions Holding LGND
# of Institutions
279Shares Held
19MCall Options Held
9.5KPut Options Held
8.1K-
Black Rock Inc. New York, NY2.87MShares$302 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.06MShares$216 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.03MShares$108 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3906KShares$95.4 Million0.12% of portfolio
-
Dimensional Fund Advisors LP Austin, TX745KShares$78.4 Million0.02% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $1.78B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...